Cargando…

Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection

HIV-1 virus-like particles (VLPs) are promising vaccine candidates against HIV-1 infection. They are capable of preserving the native conformation of HIV-1 antigens and priming CD4+ and CD8+ T cell responses efficiently via cross presentation by both major histocompatibility complex (MHC) class I an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Chongbo, Ao, Zhujun, Yao, Xiaojian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810054/ https://www.ncbi.nlm.nih.gov/pubmed/26805898 http://dx.doi.org/10.3390/vaccines4010002

Ejemplares similares

Development and Evaluation of an Ebola Virus Glycoprotein Mucin-Like Domain Replacement System as a New Dendritic Cell-Targeting Vaccine Approach against HIV-1
por: Ao, Zhujun, et al.
Publicado: (2021)

Vpr14-88-Apobec3G Fusion Protein Is Efficiently Incorporated into Vif-Positive HIV-1 Particles and Inhibits Viral Infection
por: Ao, Zhujun, et al.
Publicado: (2008)

Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection
por: Olukitibi, Titus A., et al.
Publicado: (2023)

HIV-1 envelope glycoprotein stimulates viral transcription and increases the infectivity of the progeny virus through the manipulation of cellular machinery
por: Ran, Xiaozhuo, et al.
Publicado: (2017)

R88-APOBEC3Gm Inhibits the Replication of Both Drug-resistant Strains of HIV-1 and Viruses Produced From Latently Infected Cells
por: Wang, Xiaoxia, et al.
Publicado: (2014)

Inactivation of microbial infectiousness by silver nanoparticles-coated condom: a new approach to inhibit HIV- and HSV-transmitted infection
por: Mohammed Fayaz, A, et al.
Publicado: (2012)

Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1
por: Gao, Yong, et al.
Publicado: (2018)

Dendritic Cells/Macrophages-Targeting Feature of Ebola Glycoprotein and its Potential as Immunological Facilitator for Antiviral Vaccine Approach
por: Olukitibi, Titus Abiola, et al.
Publicado: (2019)

Characterization of the Role of Host Cellular Factor Histone Deacetylase 10 during HIV-1 Replication
por: Ran, Xiaozhuo, et al.
Publicado: (2019)

Noncovalent SUMO-interaction motifs in HIV integrase play important roles in SUMOylation, cofactor binding, and virus replication
por: Zheng, Yingfeng, et al.
Publicado: (2019)

Virus‐like particles for vaccination against cancer
por: Mohsen, Mona O., et al.
Publicado: (2019)

Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses
por: Ao, Zhujun, et al.
Publicado: (2019)

Virus-Like-Vaccines against HIV
por: Andersson, Anne-Marie C., et al.
Publicado: (2018)

A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection
por: Ao, Zhujun, et al.
Publicado: (2022)

Characterization of the HIV-1 integrase chromatin- and LEDGF/p75-binding abilities by mutagenic analysis within the catalytic core domain of integrase
por: Zheng, Yingfeng, et al.
Publicado: (2010)

Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection
por: Zhang, Xu, et al.
Publicado: (2016)

Activation of HIV-1 expression in latently infected CD4+ T cells by the small molecule PKC412
por: Ao, Zhujun, et al.
Publicado: (2016)

Exploiting virus-like particles as innovative vaccines against emerging viral infections
por: Jeong, Hotcherl, et al.
Publicado: (2017)

Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2
por: Kim, Chulwoo, et al.
Publicado: (2022)

Recent Advances in the Use of Plant Virus-Like Particles as Vaccines
por: Balke, Ina, et al.
Publicado: (2020)

Virus-like Particle Display of the α-Gal Carbohydrate for Vaccination against Leishmania Infection
por: Moura, Anna Paula V., et al.
Publicado: (2017)

Contribution of the C-terminal tri-lysine regions of human immunodeficiency virus type 1 integrase for efficient reverse transcription and viral DNA nuclear import
por: Ao, Zhujun, et al.
Publicado: (2005)

Virus-Like Particles and Nanoparticles for Vaccine Development against HCMV
por: Perotti, Michela, et al.
Publicado: (2019)

Virus-Like Particle Based Vaccines Elicit Neutralizing Antibodies against the HIV-1 Fusion Peptide
por: Mogus, Alemu Tekewe, et al.
Publicado: (2020)

Oral Immunization with rVSV Bivalent Vaccine Elicits Protective Immune Responses, Including ADCC, against Both SARS-CoV-2 and Influenza A Viruses
por: Ouyang, Maggie Jing, et al.
Publicado: (2023)

Immunization with Virus-Like Particle Vaccine Protects Rabbits against Hepatitis E-3 Virus Infection
por: Go, Hyeon-Jeong, et al.
Publicado: (2022)

Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus
por: Mazalovska, Milena, et al.
Publicado: (2020)

Virus-Like Particle Systems for Vaccine Development against Viruses in the Flaviviridae Family
por: Wong, Shu Hui, et al.
Publicado: (2019)

Virus like particle-based vaccines against emerging infectious disease viruses
por: Liu, Jinliang, et al.
Publicado: (2016)

Design Concepts of Virus-Like Particle-Based HIV-1 Vaccines
por: Chen, Chun-Wei, et al.
Publicado: (2020)

Recent Advances in the Development of Virus-Like Particle-Based Flavivirus Vaccines
por: Zhang, Naru, et al.
Publicado: (2020)

Platforms, advances, and technical challenges in virus-like particles-based vaccines
por: Gupta, Reeshu, et al.
Publicado: (2023)

Decorated and Encapsulated: Virus-Like Particles Against Viral Infections
por: Temchura, Vladimir
Publicado: (2021)

Generation of virus-like particle as a vaccine strategy against bovine leukemia virus
por: Otsuki, Hiroyuki, et al.
Publicado: (2015)

Virus-like particle-based vaccines for animal viral infections
por: Crisci, Elisa, et al.
Publicado: (2013)

Production of virus-like particles for vaccines
por: Fuenmayor, J., et al.
Publicado: (2017)

Virus-Like Particle and Nanoparticle Vaccines
por: Kanekiyo, M., et al.
Publicado: (2017)

Respiratory Viruses and Virus-like Particle Vaccine Development: How Far Have We Advanced?
por: Chu, Ki-Back, et al.
Publicado: (2023)

Pigs Immunized with the Virus-like Particle Vaccine Are Protected against the Hepatitis E-3 Virus
por: Go, Hyeon-Jeong, et al.
Publicado: (2021)

Virus-like particles: The new frontier of vaccines for animal viral infections
por: Crisci, Elisa, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ftief06jiq89kke12e5nie1kcp